UNSPSC 51192004: Sulfinpyrazone

This classification denotes a uricosuric agent with the molecular formula C23H20N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V6OFU47K3W, chemically known as 3,5-pyrazolidinedione, 1,2-diphenyl-4-(2-(phenylsulfinyl)ethyl)- but generally known as sulfinpyrazone, which bears US NIH Compound Identifier 5342. European Medicines Agency schedules Sulfinpyrazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10737MIG.

UNSPSC 51192004 Sulfinpyrazone, a Commodity-tier code, shows a mismatch between its nominal scope and recent state and local procurement activity. Sulfinpyrazone is a uricosuric agent used to treat gout and hyperuricemia, but the three most recent opportunities tagged under this code involve athletic training services for fire and police departments, general medical aid supplies for fire rescue operations, and a Texas Health and Human Services Commission request for information on direct-to-manufacturer prescription fulfillment programs. None of these solicitations involve sulfinpyrazone procurement, suggesting the code may be incorrectly applied or that the commodity experiences minimal direct purchasing activity through state and local channels.

The three opportunities span different issuing bodies and geographies — the City of Tucson (RFP for athletic training services, due June 9, 2026), the City of Tampa Fire Rescue Department (ITB for medical aid supplies including first aid and antiseptic items, originally due April 9, 2025), and the Texas Health and Human Services Commission (RFI on direct-to-manufacturer prescription programs, response deadline April 3, 2026) — but none reflect procurement of sulfinpyrazone or related uricosuric pharmaceuticals. The code shows little relevant recent activity and does not support a clear signal about state and local buying patterns or vendor opportunity under its stated pharmaceutical scope.